Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Protalix BioTherapeutics (PLX) Asset Utilization Ratio (2016 - 2025)

Protalix BioTherapeutics (PLX) has 14 years of Asset Utilization Ratio data on record, last reported at 0.77 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio rose 28.97% year-over-year to 0.77; the TTM value through Sep 2025 reached 0.77, up 28.97%, while the annual FY2024 figure was 0.68, 27.57% down from the prior year.
  • Asset Utilization Ratio reached 0.77 in Q3 2025 per PLX's latest filing, down from 0.81 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.87 in Q2 2023 and bottomed at 0.42 in Q2 2024.
  • Average Asset Utilization Ratio over 5 years is 0.68, with a median of 0.7 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: plummeted 51.8% in 2024, then skyrocketed 93.76% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.49 in 2021, then skyrocketed by 73.52% to 0.85 in 2022, then fell by 10.08% to 0.76 in 2023, then increased by 3.9% to 0.79 in 2024, then decreased by 2.76% to 0.77 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.77 in Q3 2025, 0.81 in Q2 2025, and 0.81 in Q1 2025.